Evaluation of the Pathogenesis of Decreasing CD4+ T Cell Counts in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy

Nies-Kraske, Elizabeth; Schacker, Timothy W.; Condoluci, David; Orenstein, Jan; Brenchley, Jason; Fox, Cecil; Daucher, Marybeth; Dewar, Robin; Urban, Elizabeth; Hill, Brenna; Guenaga, Javier; Hoover, Shelley; Maldarelli, Frank; Hallahan, Claire W.; Horn, Judith; Kottilil, Shyamasundaran; Tae-Wook Chun; Folino, Marlene; Palmer, Sara; Wiegand, Ann
June 2009
Journal of Infectious Diseases;6/1/2009, Vol. 199 Issue 11, p1648
Academic Journal
Most human immunodeficiency virus (HIV)-infected individuals experience increases in peripheral CD4+ T cell counts with suppressive antiretroviral therapy (ART) that achieves plasma HIV RNA levels that are less than the limit of detection. However, some individuals experience decreasing CD4+ T cell counts despite suppression of plasma viremia. We evaluated 4 patients with a history of CD4+ T cell decline despite successfully suppressive ART, from a median of 719 cells/mm3 (range, 360-1141 cells/mm3) to 227 cells/mm3 (range, 174-311 cells/mm3) over a period of 18-24 months; 3 of the patients were receiving tenofovir and didanosine, which may have contributed to this decrease. There was no evidence of HIV replication, nor of antiretroviral drug resistance in the blood or lymphoid tissue, or increased proliferation or decreased thymic production of naive CD4+ T cells. All 4 patients had significant fibrosis of the T cell zone of lymphoid tissue, which appeared to be an important factor in the failure to reconstitute T cells.


Related Articles

  • GPs urged to cutrates of late HIV diagnosis. Moberly, Tom // GP: General Practitioner;4/10/2009, p16 

    The article focuses on the encouragement for general practitioners (GPs) to cut rates of late HIV diagnosis in Great Britain. Professor Margaret Johnson notes about a third of HIV patients in the country present late. She points out that patients with CD4 cell counts between 200 and 350 tends to...

  • Human TRIM5α Expression Levels and Reduced Susceptibility to HIV-1 Infection. Sewram, Shamman; Singh, Ravesh; Kormuth, Emil; Werner, Lise; Mlisana, Koleka; Karim, S. S. Abdool; Ndung'u, Thumbi // Journal of Infectious Diseases;6/1/2009, Vol. 199 Issue 11, p1657 

    Background. Human TRIM5α (TRIM5αhu), a member of the tripartite motif protein family, displays some anti-human immunodeficiency virus type 1 (HIV-1) activity in vitro, although it is substantially less potent than its rhesus monkey counterpart (TRIM5αrh). The effects of levels of...

  • Modelling the Impact of Antiretroviral Use in Resource-Poor Settings. Baggaley, Rebecca F.; Garnett, Geoff P.; Ferguson, Neil M. // PLoS Medicine;Apr2006, Vol. 3 Issue 4, pe124 

    Background: The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-constrained settings requires operational research to guide policy on the design of treatment programmes. Mathematical models can explore the potential impacts of various treatment strategies,...

  • Development of genetically engineered CD4 and CD8 T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen. Wei Luo; Xiao-Bing Zhang; Yong-Ta Huang; Pei-Pei Hao; Zhen-Min Jiang; Qian Wen; Ming-Qian Zhou; Qi Jin; Li Ma // Journal of Molecular Medicine;Sep2011, Vol. 89 Issue 9, p903 

    Cell-mediated immunity is critical to the clearance of Mycobacterium tuberculosis due to the primarily intracellular niche of this pathogen. Adoptive transfer of M. tuberculosis-specific effector T cells has been shown to confer immunity to M. tuberculosis-infected recipients resulting in M....

  • The effects of galectin-1 on the gene expression of the transcription factors TBX21, GATA-3, FOXP3 and RORC. Ryazantseva, N.; Novitsky, V.; Yakushina, V.; Vasil'eva, O.; Tashireva, L. // Molecular & Cellular Biochemistry;Jan2015, Vol. 398 Issue 1/2, p245 

    CD4 T cells orchestrate the immune response by differentiating into T helper (Th) or regulatory (Treg) cell subsets that secrete distinct sets of cytokines. They also play a critical role in the pathogenesis of autoimmunity, asthma, allergy and, likely, cancer. The mechanisms involved in the...

  • Therapeutic potential of hyporesponsive CD4+ T cells in autoimmunity. Maggi, Jaxaira; Schafer, Carolina; Ubilla-Olguín, Gabriela; Catalán, Diego; Schinnerling, Katina; Aguillón, Juan C.; Tarbell, Kristin; Karin, Nathan // Frontiers in Immunology;Sep2015, p1 

    The interaction between dendritic cells (DCs) and T cells is crucial on immunity or tolerance induction. In an immature or semi-mature state, DCs induce tolerance through T-cell deletion, generation of regulatory T cells, and/or induction of T-cell anergy. Anergy is defined as an unresponsive...

  • HIV vaccines: mosaic approach to virus diversity. Corey, Lawrence; McElrath, M. Juliana // Nature Medicine;Mar2010, Vol. 16 Issue 3, p268 

    The article discusses the mosaic vaccine approach to HIV genetic diversity. It emphasizes the approach's application to in silico algorithms for vaccine gene or protein selection. It analyzes two studies which discover the potential of vaccines to improve the diversity of immune responses to...

  • Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice. Hauber, Ilona; Hofmann-Sieber, Helga; Chemnitz, Jan; Dubrau, Danilo; Chusainow, Janet; Stucka, Rolf; Hartjen, Philip; Schambach, Axel; Ziegler, Patrick; Hackmann, Karl; Schröck, Evelin; Schumacher, Udo; Lindner, Christoph; Grundhoff, Adam; Baum, Christopher; Manz, Markus G.; Buchholz, Frank; Hauber, Joachim // PLoS Pathogens;Sep2013, Vol. 9 Issue 9, p1 

    Stable integration of HIV proviral DNA into host cell chromosomes, a hallmark and essential feature of the retroviral life cycle, establishes the infection permanently. Current antiretroviral combination drug therapy cannot cure HIV infection. However, expressing an engineered HIV-1 long...

  • Data vs. Dogma: HIV-1 Integrations Driving Clonal Selection. Baum, Christopher // Molecular Therapy;Sep2014, Vol. 22 Issue 9, p1557 

    The author reflects on HIV type 1 (HIV-1) integration and its influence on clonal selection during HIV-1 replication, focusing on the development of gene vector based on the virus due to the lack of evidence that HIV-1 integration is oncogenic. He explores the introduction of combinatorial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics